BioPharma Drug Discovery
AbbVie Secures EU Approval for TEPKINLY® as First Subcutaneous Bispecific Antibody for Relapsed Follicular Lymphoma
AbbVie announced that the European Commission (EC) has granted conditional marketing authorization for TEPKINLY® (epcoritamab) as a monotherapy fo...
August 20, 2024 | News
AbbVie Secures EU Approval for TEPKINLY® as First Subcutaneous Bispecific Antibody for Relapsed Follicular Lymphoma
AbbVie announced that the European Commission (EC) has granted conditional marketing authorization for TEPKINLY® (epcoritamab) as a monotherapy fo...
August 20, 2024 | News
Astellas Pharma Gains NMPA Approval for PADCEV™ in China to Treat Advanced Urothelial Cancer
Astellas Pharma Inc. (TSE:4503, President and CEO: Naoki Okamura, "Astellas") announced that the Center for Drug Evaluation (CDE) of C...
August 20, 2024 | News
Akeso’s Ivonescimab Granted Priority Review by China's NMPA for First-Line Treatment of PD-L1 Positive NSCLC
Akeso, Inc. announced that the National Center for Drug Evaluation of the State Drug Administration of the People's Republic of China (NMPA CDE) ...
August 15, 2024 | News
AI Meets Life Sciences: How HKSTP and BioMap Are Transforming Hong Kong’s Biotech Landscape
In an exclusive interview with BioPharma APAC, Dr. Grace Lau, Head of Institute for Translational Research at Hong Kong Science and Technology Parks Corpor...
August 14, 2024 | Interview
UAE Approves LEQEMBI® for Early Alzheimer’s Treatment, Marking a Milestone in Regional Healthcare
Eisai Co., Ltd. and Biogen Inc. announced today that the Ministry of Health and Prevention in the United Arab Emirates (UAE) has approved humanized anti-so...
August 14, 2024 | News
Sable Therapeutics Secures Exclusive Worldwide Licensing Deal with Columbia University to Advance Cutting-Edge Fat Reduction Nanomedicines
Sable Therapeutics, an innovative early stage drug development company focused on pioneering fat reduction therapies, announced an exclusive worldwid...
August 12, 2024 | News
Formosa Pharmaceuticals and Eyenovia to Co-Develop Clobetasol Propionate for Dry Eye Disease
Taiwan-based Formosa Pharmaceuticals ("Formosa", 6838.TWO) announced today that the company has signed a non-binding terms agreement with Eyenovia, Inc. ("...
August 08, 2024 | News
Senhwa Biosciences Receives FDA Green Light for Phase I/II Trial of Silmitasertib in Pediatric Relapsed Refractory Solid Tumors
Senhwa Biosciences, Inc. (TPEx: 6492), a drug development company focusing on first-in-class therapeutics for oncology, rare diseases, and infectious disea...
August 07, 2024 | News
Cresset and Enamine Expand Global Collaboration to Enhance Targeted Protein Degradation Research
Cresset, an innovative provider of integrated in silico solutions for drug discovery, announces an extension of the global collaboration with Ena...
August 06, 2024 | News
Medicilon and Hengrui Pharma Forge Strategic Partnership to Accelerate Preclinical Drug Development
Shanghai Medicilon Inc. ("Medicilon") and Jiangsu Hengrui Pharmaceuticals Co., Ltd. ("Hengrui Pharma") reached a strategic collaboration agreement.&nb...
August 01, 2024 | News
$2 Million Grant Fuels Queensland Drug Discovery Alliance to Propel Therapeutic Innovations
A $2 million grant awarded to establish the Queensland Drug Discovery Alliance (QDDA) will align and grow Queensland’s small molecule therapeutic dis...
July 31, 2024 | News
Clarivate Launches Enhanced OFF-X™ Platform to Transform Drug Safety Intelligence
Clarivate Plc a leading global provider of transformative intelligence, today announced the launch of the new OFF-X™ platform. The en...
July 31, 2024 | News
ReviR Therapeutics Secures $30M Series A Financing to Advance AI-Driven RNA Modulator Platform
ReviR Therapeutics, an AI-enabled biotechnology company focused on developing small molecule RNA modulators for neurogenetic diseases, announced today that...
July 29, 2024 | News
Most Read
- Lack of Regular Screening Fuels Rise in Late-Stage Breast Cancer in Hong Kong, New Report Reveals
- BIOCHINA 2025: Connecting Global Innovators with China's Leading Biotech Firms
- Leon Wyszkowski, President of Analytical Services, Discusses Thermo Fisher's Strategic Move: Expanding Bioanalytical Capabilities in Europe with New Sweden Lab
- The Role of Policy and Public Health Initiatives in Addressing Women's Cancer Care in Asia
- Redefining Patient Safety in the Age of Healthtech
Bio Jobs
- Avance Clinical Appoints Jessica Han as Director of Asian Operations, Strengthening Commitment to the Asian Market
- Bristol Myers Squibb Employees Cycle Coast-to-Coast to Raise $1 Million for Cancer Research
- Pfizer Australia Commits $150M to Upgrade Melbourne Facility, Bolstering Global Fight Against Antimicrobial Resistance
- SMi Systems Appoints Dr. Stefan Hamill as Vice President of Strategy to Drive Commercialisation and Growth
- Thermo Fisher Scientific Appoints William Hung as Senior Director and General Manager for Taiwan
- Cytiva Appoints Industry Veteran Pierre-Alain Ruffieux as Chief Operating Officer
News
